439 related articles for article (PubMed ID: 19797525)
21. Donor Dependent Variations in Hematopoietic Differentiation among Embryonic and Induced Pluripotent Stem Cell Lines.
Féraud O; Valogne Y; Melkus MW; Zhang Y; Oudrhiri N; Haddad R; Daury A; Rocher C; Larbi A; Duquesnoy P; Divers D; Gobbo E; Brunet de la Grange P; Louache F; Bennaceur-Griscelli A; Mitjavila-Garcia MT
PLoS One; 2016; 11(3):e0149291. PubMed ID: 26938212
[TBL] [Abstract][Full Text] [Related]
22. Bone marrow mesenchymal stromal cells of patients with myeloproliferative disorders do not carry the JAK2-V617F mutation.
Mercier F; Monczak Y; François M; Prchal J; Galipeau J
Exp Hematol; 2009 Mar; 37(3):416-20. PubMed ID: 19135773
[TBL] [Abstract][Full Text] [Related]
23. Phenotypic variability within the JAK2 V617F-positive MPD: roles of progenitor cell and neutrophil allele burdens.
Moliterno AR; Williams DM; Rogers O; Isaacs MA; Spivak JL
Exp Hematol; 2008 Nov; 36(11):1480-6. PubMed ID: 18723264
[TBL] [Abstract][Full Text] [Related]
24. [Biological characteristics of mesenchymal stem cells in human umbilical cord blood and their supporting capacities in ex vivo expansion of CD34+ hematopoietic stem cells].
Wang LJ; Zhang YP; Wang JF; Wu YF; Xiang Y; Xie CG; Jia BB; Harrington J; McNiece IK
Zhonghua Xue Ye Xue Za Zhi; 2005 Feb; 26(2):65-8. PubMed ID: 15921619
[TBL] [Abstract][Full Text] [Related]
25. Prospectively Isolated Human Bone Marrow Cell-Derived MSCs Support Primitive Human CD34-Negative Hematopoietic Stem Cells.
Matsuoka Y; Nakatsuka R; Sumide K; Kawamura H; Takahashi M; Fujioka T; Uemura Y; Asano H; Sasaki Y; Inoue M; Ogawa H; Takahashi T; Hino M; Sonoda Y
Stem Cells; 2015 May; 33(5):1554-65. PubMed ID: 25537923
[TBL] [Abstract][Full Text] [Related]
26. Hematopoietic and endothelial progenitor cell trafficking in patients with myeloproliferative diseases.
Oppliger Leibundgut E; Horn MP; Brunold C; Pfanner-Meyer B; Marti D; Hirsiger H; Tobler A; Zwicky C
Haematologica; 2006 Nov; 91(11):1465-72. PubMed ID: 17082007
[TBL] [Abstract][Full Text] [Related]
27. Immunoproteasome Genes Are Modulated in CD34
Di Rosa M; Giallongo C; Romano A; Tibullo D; Li Volti G; Musumeci G; Barbagallo I; Imbesi R; Castrogiovanni P; Palumbo GA
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331228
[TBL] [Abstract][Full Text] [Related]
28. Gene and miRNA expression profiles of hematopoietic progenitor cells vary depending on their origin.
Báez A; Martín-Antonio B; Piruat JI; Barbado MV; Prats C; Álvarez-Laderas I; Carmona M; Pérez-Simón JA; Urbano-Ispizua Á
Biol Blood Marrow Transplant; 2014 May; 20(5):630-9. PubMed ID: 24462744
[TBL] [Abstract][Full Text] [Related]
29. iPSC-derived mesenchymal stromal cells are less supportive than primary MSCs for co-culture of hematopoietic progenitor cells.
Vasko T; Frobel J; Lubberich R; Goecke TW; Wagner W
J Hematol Oncol; 2016 Apr; 9():43. PubMed ID: 27098268
[TBL] [Abstract][Full Text] [Related]
30. Genome editing to model and reverse a prevalent mutation associated with myeloproliferative neoplasms.
Baik R; Wyman SK; Kabir S; Corn JE
PLoS One; 2021; 16(3):e0247858. PubMed ID: 33661998
[TBL] [Abstract][Full Text] [Related]
31. The timing of retroviral silencing correlates with the quality of induced pluripotent stem cell lines.
Okada M; Yoneda Y
Biochim Biophys Acta; 2011 Feb; 1810(2):226-35. PubMed ID: 20965232
[TBL] [Abstract][Full Text] [Related]
32. The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disorders.
Michiels JJ; De Raeve H; Berneman Z; Van Bockstaele D; Hebeda K; Lam K; Schroyens W
Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):307-40. PubMed ID: 16810609
[TBL] [Abstract][Full Text] [Related]
33. Successful generation of donor specific hematopoietic stem cell lines from co-cultured bone marrow with human embryonic stem cell line: a new methodology.
Vanikar AV; Mishra VV; Firoz A; Shah VR; Dave SD; Patel RD; Kanodia KV; Patel JV; Patel CN; Trivedi HL
Transplant Proc; 2007 Apr; 39(3):658-61. PubMed ID: 17445567
[TBL] [Abstract][Full Text] [Related]
34. Characterization of murine JAK2V617F-positive myeloproliferative disease.
Bumm TG; Elsea C; Corbin AS; Loriaux M; Sherbenou D; Wood L; Deininger J; Silver RT; Druker BJ; Deininger MW
Cancer Res; 2006 Dec; 66(23):11156-65. PubMed ID: 17145859
[TBL] [Abstract][Full Text] [Related]
35. Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures.
Chou BK; Mali P; Huang X; Ye Z; Dowey SN; Resar LM; Zou C; Zhang YA; Tong J; Cheng L
Cell Res; 2011 Mar; 21(3):518-29. PubMed ID: 21243013
[TBL] [Abstract][Full Text] [Related]
36. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells.
Zhou W; Freed CR
Stem Cells; 2009 Nov; 27(11):2667-74. PubMed ID: 19697349
[TBL] [Abstract][Full Text] [Related]
37. Memory in induced pluripotent stem cells: reprogrammed human retinal-pigmented epithelial cells show tendency for spontaneous redifferentiation.
Hu Q; Friedrich AM; Johnson LV; Clegg DO
Stem Cells; 2010 Nov; 28(11):1981-91. PubMed ID: 20882530
[TBL] [Abstract][Full Text] [Related]
38. Hematopoietic development from human induced pluripotent stem cells.
Lengerke C; Grauer M; Niebuhr NI; Riedt T; Kanz L; Park IH; Daley GQ
Ann N Y Acad Sci; 2009 Sep; 1176():219-27. PubMed ID: 19796250
[TBL] [Abstract][Full Text] [Related]
39. JAK2V617F expression in mice amplifies early hematopoietic cells and gives them a competitive advantage that is hampered by IFNα.
Hasan S; Lacout C; Marty C; Cuingnet M; Solary E; Vainchenker W; Villeval JL
Blood; 2013 Aug; 122(8):1464-77. PubMed ID: 23863895
[TBL] [Abstract][Full Text] [Related]
40. Cell fusion enhances mesendodermal differentiation of human induced pluripotent stem cells.
Qin J; Sontag S; Lin Q; Mitzka S; Leisten I; Schneider RK; Wang X; Jauch A; Peitz M; Brüstle O; Wagner W; Zhao RC; Zenke M
Stem Cells Dev; 2014 Dec; 23(23):2875-82. PubMed ID: 25004077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
